Neoadjuvant gemcitabine, docetaxel, and capecitabine followed by gemcitabine and capecitabine/radiation therapy and surgery in locally advanced, unresectable pancreatic adenocarcinoma. [electronic resource]
Producer: 20150504Description: 673-80 p. digitalISSN:- 1097-0142
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Capecitabine
- Combined Modality Therapy
- Deoxycytidine -- adverse effects
- Docetaxel
- Female
- Fluorouracil -- adverse effects
- Humans
- Male
- Middle Aged
- Neoadjuvant Therapy -- methods
- Neoplasm Recurrence, Local -- epidemiology
- Pancreatic Neoplasms -- drug therapy
- Prospective Studies
- Taxoids -- adverse effects
- Treatment Outcome
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.